The RWJF-funded Placebo Seminar Series continued on February 11, 2014 with an address by Tanya Luhrmann, Watkins University Professor in the Stanford Anthropology Department. Discussants were: Arthur Kleinman (Anthropology, Psychiatry), Anne Harrington (History of Science), and Ted Kaptchuk (Medicine). View the lecture and discussion in full here.
If you were not able to attend or tune in to our December 9th forum on placebo effects in the clinic, we’re happy to announce you can watch it now.
View the webcast here.
You can also join the conversation online by following the Twitter hashtag #placebotalks.
• Michael J. Barry, MD, President, Informed Medical Decisions Foundation
• Josephine P. Briggs, MD, Director, NCCAM, National Institutes of Health
• Joann G. Elmore, MD, MPH, Professor of Medicine, University of Washington
• Russell S. Phillips, MD, Director, HMS Center for Primary Care
• Harold C. Sox, MD, Associate Director, Dartmouth Institute for Health Policy & Clinical Practice
“The placebo effect is people getting better without any active ingredients.” Harvard Medical School’s Ted Kaptchuk, a Robert Wood Johnson Foundation grantee, cuts across clinical specialties through robust research and specialized technologies, to understand and institutionalize one of the most exciting, and controversial ideas in modern medicine.
Watch the video here.
Four renowned experts in the field of placebo studies convened at Harvard to share their findings with the medical community. View the talks and download bios, slides and other documents:
June 19th: Fabrizio Benedetti (Turin) and Tor Wager (Colorado)
June 20th: Predrag Petrovic (Karolinska) and Ted Kaptchuk (Harvard)
A very short ‘highlights’ video.
The experiment involved taking scans of physicians’ brains while they were delivering treatment. The findings support the idea that patient–physician interactions significantly contribute to placebo effects and clinical outcomes. Read the full article here.
Based on extensive interviews with Ted Kaptchuk and a number of his colleagues and associates, this article sums up the ground-breaking work that Prof. Kaptchuk has overseen. Read the full text of the article here.
PiPS has been awarded $250,000 by the Robert Wood Johnson Foundation. The funds will be used to create a high-impact seminar series that examines the potential of placebo studies to contribute to the transformation of health care. Over a period of approximately 18 months starting in June, 2013, a series of symposia will be held that bring together representatives from relevant disciplines including clinical specialties, neuroscience, health policy, anthropology, sociology, bioethics, and the history of medicine. The symposia will be structured to encourage an in-depth conversation that broadens the discourse about how the phenomenon known as placebo response can be utilized to enhance the provider-patient relationship, improve patient outcomes, reduce morbidity, and help control health care costs. Incentives will be offered that encourage participants to engage in collaborations. Certain events will be open to the public as well as the medical community. Register as a member to learn more about these and other events. Or call 617-945-7827 for more information.
A patient’s genetic makeup may explain the “placebo effect,” in which people perceive that a fake treatment makes them feel better, according to a study by PiPS researchers. The findings may help researchers design better clinical trials.
Read the article: “Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome”
Radio Boston (local NPR station) interviews PiPS Director, Ted Kaptchuk, and Arthur Barsky, Director of Psychiatric Research at Brigham and Women’s Hopsital and professor at Harvard Medical School, on ethical and other questions relating to the nocebo effect.
PiPS researcher, Karin Jensen, was the lead investigator for the experiment that made these remarkable findings.
Read the article: “Nonconscious activation of placebo and nocebo pain responses”